LncRNA Neat1 promotes the macrophage inflammatory response and acts as a therapeutic target in titanium particle-induced osteolysis. (1st April 2022)

• Record Type: Journal Article
• Authors: Lin, Sipeng; Wen, Zhenkang; Li, Shixun; Chen, Zhong; Li, Changchuan; Ouyang, Zhuji; Lin, Chuangxin; Kuang, Manyuan; Xue, Chunyu; Ding, Yue
• Is Part Of: Acta biomaterialia. Volume 142(2022)
• Page Start: 345
• Page End: 360
• Publication Date: 2022-04-01
• Subjects: Aseptic loosening -- lncRNAs -- Macrophage inflammatory response -- Microparticles -- Osteolysis; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2022.02.007
• Languages: English
• ISSNs: 1742-7061

Abstract

ABSTRACT: Aseptic loosening (AL), secondary to particle-caused periprosthetic osteolysis, is one of the main reasons of artificial joint failure. Suppressing the macrophage inflammatory response caused by wear particles extends the life of prosthesis, and the long noncoding RNAs (lncRNAs) may play a predominant part in it. Here, titanium particles' (TiPs') stimulation increases both the cytoplasmic and nuclear levels of lncRNA Neat1 in bone marrow derived macrophages (BMDMs), which further induces the inflammatory response. Mechanically, Neat1 facilitates Bruton's tyrosine kinase (BTK) transcription by reducing the transcriptional factor KLF4, which further activates the NF-κB pathway, NLRP3 inflammation, and M1 polarization in BMDMs. Cytoplasmic Neat1 also works as an miRNA sponge in miR-188–5p-regulated BTK expression in the post-transcriptional stage. In vivo, Neat1 downregulation can reduce the TiP-induced pro-inflammatory factors and reverse the osteolysis induced by BTK overexpression. In addition, the PLGA-based microparticles loaded with si- Neat1 are developed for the treatment of the mouse calvarial osteolysis model via local injection, presenting satisfactory anti-osteolysis efficacy. These findings indicate that Neat1 is a key regulator of AL. Statement of significance: Due to released particles, aseptic loosening (AL) is the most common reason for prosthesis failure and surgical revision and represents a substantial economic burden worldwide. Herein, we reported that lncRNA Neat1 is a key regulator in regulating wear particles-induced osteolysis by activating NF-κB pathway, NLRP3 inflammation and M1 polarization via BTK, and the underlying mechanisms of Neat1 -BTK interaction were further portrayed. For potential clinical application, the microparticles are developed for effective si- Neat1 delivery, leading to a dramatically enhanced effect for the treatment of osteolysis, which might be a novel strategy to extend the life of the implant. Graphical abstract: Image, graphical abstract